Ignite Creation Date:
2025-12-17 @ 3:48 PM
Ignite Modification Date:
2025-12-23 @ 11:16 PM
Study NCT ID:
NCT00749632
Status:
COMPLETED
Last Update Posted:
2009-10-15
First Post:
2008-09-05
Is Possible Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
A Study of Oxybutynin for the Treatment of Urge Urinary Incontinence
Sponsor:
FemmePharma Global Healthcare, Inc.
Organization:
Study Overview
Official Title:
An Open-Label, Dose Escalating Study to Evaluate the Safety of Intravaginal Oxybutynin in Subjects With Urge Urinary Incontinence
Status:
COMPLETED
Status Verified Date:
2009-10
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
FP1097-002
Brief Summary:
The purpose of this study is to determine the safety of three doses of oxybutynin for the treatment of urge urinary incontinence.
Detailed Description:
None
Study Oversight
Has Oversight DMC:
False
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: